AstraZeneca Pharma India Limited (ASTRAZEN.BO)

INR 6485.35

(0.07%)

Total Debt Summary of AstraZeneca Pharma India Limited

  • AstraZeneca Pharma India Limited's latest annual total debt in 2023 was 45.98 Million INR , down -36.22% from previous year.
  • AstraZeneca Pharma India Limited's latest quarterly total debt in 2023 FY was 45.98 Million INR , down -36.22% from previous quarter.
  • AstraZeneca Pharma India Limited reported annual total debt of 72.1 Million INR in 2022, down -16.45% from previous year.
  • AstraZeneca Pharma India Limited reported annual total debt of 86.3 Million INR in 2021, down -28.91% from previous year.
  • AstraZeneca Pharma India Limited reported quarterly total debt of - INR for 2023 Q3, down -100.0% from previous quarter.
  • AstraZeneca Pharma India Limited reported quarterly total debt of 53.47 Million INR for 2023 Q2, down 0.0% from previous quarter.

Annual Total Debt Chart of AstraZeneca Pharma India Limited (2023 - 2005)

Historical Annual Total Debt of AstraZeneca Pharma India Limited (2023 - 2005)

Year Total Debt Total Debt Growth
2023 45.98 Million INR -36.22%
2022 72.1 Million INR -16.45%
2021 86.3 Million INR -28.91%
2020 121.4 Million INR 2.53%
2019 118.4 Million INR 0.0%
2018 - INR 0.0%
2017 - INR 0.0%
2016 - INR 0.0%
2015 - INR -100.0%
2014 2.75 Million INR 0.0%
2013 2.75 Million INR -5.54%
2012 2.91 Million INR 0.0%
2011 2.91 Million INR 0.0%
2010 - INR -100.0%
2009 9.86 Million INR -98.45%
2008 634.86 Million INR 6338.74%
2007 9.86 Million INR 0.0%
2006 9.86 Million INR 0.0%
2005 9.86 Million INR 0.0%

Peer Total Debt Comparison of AstraZeneca Pharma India Limited

Name Total Debt Total Debt Difference
Ajanta Pharma Limited 352.8 Million INR 86.967%
Amrutanjan Health Care Limited 17.28 Million INR -166.053%
Sigachi Industries Limited 1.43 Billion INR 96.786%
Bal Pharma Limited 1.39 Billion INR 96.707%
Ind-Swift Laboratories Limited 166.21 Million INR 72.336%
Medico Remedies Limited 80.5 Million INR 42.882%
Lasa Supergenerics Limited 220.76 Million INR 79.171%
Venus Remedies Limited 413.3 Million INR 88.874%
Sun Pharma Advanced Research Company Limited 611.5 Million INR 92.48%
Alpa Laboratories Limited 52.46 Million INR 12.357%
Nectar Lifesciences Limited 6.35 Billion INR 99.276%
Shilpa Medicare Limited 9.37 Billion INR 99.509%
Aarti Drugs Limited 5.64 Billion INR 99.185%
Lupin Limited 29.21 Billion INR 99.843%
Aurobindo Pharma Limited 66.47 Billion INR 99.931%
Zydus Lifesciences Limited 8.04 Billion INR 99.428%
Windlas Biotech Limited 36.41 Million INR -26.289%
Suven Life Sciences Limited 7.09 Million INR -547.908%
Eris Lifesciences Limited 27.81 Billion INR 99.835%
Valiant Laboratories Limited 767.08 Million INR 94.006%
J. B. Chemicals & Pharmaceuticals Limited 3.77 Billion INR 98.782%
Solara Active Pharma Sciences Limited 10.11 Billion INR 99.545%
Ipca Laboratories Limited 14.38 Billion INR 99.68%
Bliss GVS Pharma Limited 998.4 Million INR 95.394%
Achyut Healthcare Limited - INR -Infinity%
Sun Pharmaceutical Industries Limited 32.73 Billion INR 99.86%
Bajaj HealthCare Limited 3.32 Billion INR 98.618%
RPG Life Sciences Limited - INR -Infinity%
Mankind Pharma Limited 2.07 Billion INR 97.78%
Laurus Labs Limited 25.77 Billion INR 99.822%
Piramal Pharma Limited 47.1 Billion INR 99.902%
Syncom Formulations (India) Limited 724.86 Million INR 93.656%
Torrent Pharmaceuticals Limited 40.22 Billion INR 99.886%
Alembic Pharmaceuticals Limited 5.13 Billion INR 99.104%
Glenmark Pharmaceuticals Limited 12.3 Billion INR 99.626%
Unichem Laboratories Limited 2.47 Billion INR 98.142%
Sequent Scientific Limited 4.87 Billion INR 99.057%
Novartis India Limited 69.7 Million INR 34.029%
Wanbury Limited 1.16 Billion INR 96.053%
Suven Pharmaceuticals Limited 649.96 Million INR 92.925%
Wockhardt Limited 23.56 Billion INR 99.805%
Themis Medicare Limited 957.92 Million INR 95.2%
Jagsonpal Pharmaceuticals Limited 89.41 Million INR 48.572%
Jubilant Pharmova Limited 36.64 Billion INR 99.875%
Glenmark Life Sciences Limited 171.48 Million INR 73.185%
Dr. Reddy's Laboratories Limited 20.02 Billion INR 99.77%
Divi's Laboratories Limited 30 Million INR -53.273%
NATCO Pharma Limited 3.71 Billion INR 98.761%
Gufic Biosciences Limited 3.32 Billion INR 98.619%
IOL Chemicals and Pharmaceuticals Limited 327.6 Million INR 85.964%
Ind-Swift Limited 10.13 Billion INR 99.547%
Procter & Gamble Health Limited 95.6 Million INR 51.902%
FDC Limited 205.18 Million INR 77.59%
Krebs Biochemicals & Industries Limited 1.93 Billion INR 97.623%
Granules India Limited 13.15 Billion INR 99.65%
Medicamen Biotech Limited 308.17 Million INR 85.079%
Alkem Laboratories Limited 14.18 Billion INR 99.676%
Biofil Chemicals and Pharmaceuticals Limited 4.38 Million INR -947.665%
Brooks Laboratories Limited 56.41 Million INR 18.499%
Megasoft Limited 1.47 Billion INR 96.873%
ZIM Laboratories Limited 1.08 Billion INR 95.775%
Strides Pharma Science Limited 25.16 Billion INR 99.817%
Neuland Laboratories Limited 953.89 Million INR 95.18%
Morepen Laboratories Limited 289.99 Million INR 84.144%
Hikal Limited 8.17 Billion INR 99.438%
Indoco Remedies Limited 6.71 Billion INR 99.316%
Aarti Pharmalabs Limited 2.85 Billion INR 98.388%
Kilitch Drugs (India) Limited 316.46 Million INR 85.47%
Mangalam Drugs & Organics Limited 984.92 Million INR 95.331%
Hester Biosciences Limited 2.44 Billion INR 98.118%